Faculty Reviews

Home Browse Faculty Reviews
921-940 of 2,125 FACULTY REVIEWS
Previous Next
 in 

Faculty Reviews are review articles written by the prestigious Members of Faculty Opinions. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.

https://doi.org/10.12688/f1000research.10464.1
Review metrics
DNA nanochannels
[version 1; peer review: 2 approved]
Dianming Wang, Yiyang Zhang, Dongsheng Liu
Peer Reviewers Thomas LaBean; Jørgen Kjems
  • Funders
  • National Basic Research Program of China (973 program)
  • National Natural Science Foundation of China
PUBLISHED 18 Apr 2017
https://doi.org/10.12688/f1000research.10794.1
Review metrics
Recent advances in preoperative management of esophageal adenocarcinoma
[version 1; peer review: 2 approved]
Kazuto Harada, Dilsa Mizrak Kaya, Hideo Baba, Jaffer A. Ajani
Peer Reviewers Rupert Langer; Efriede Bollschweiler
  • Funders
  • Schecter Private Foundation
  • National Cancer Institute and Department of Defense awards
  • Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers from Japan Society Grant
  • Rivercreek Foundation
  • The University of Texas M. D. Anderson Cancer Center
PUBLISHED 18 Apr 2017
https://doi.org/10.12688/f1000research.10652.1
Review metrics
Selective vulnerabilities and biomarkers in neurocognitive aging
[version 1; peer review: 4 approved]
Zachariah Reagh, Michael Yassa
Peer Reviewers Peter R Rapp; Morgan D Barense; Heikki Tanila; Michela Gallagher
  • Funders
  • ARCS and Roche Foundations
  • National Institute of Mental Health
  • National Institute on Aging
  • National Science Foundation
PUBLISHED 13 Apr 2017
https://doi.org/10.12688/f1000research.10859.1
Review metrics
The evolution of medulloblastoma therapy to personalized medicine
[version 1; peer review: 3 approved]
Soma Sengupta, Daniel Pomeranz Krummel, Scott Pomeroy
Peer Reviewers James T Rutka; Sridharan Gururangan; Charles Eberhart
  • Funders
  • National Institute of Neurological Disorders and Stroke
  • American Cancer Society
PUBLISHED 13 Apr 2017
https://doi.org/10.12688/f1000research.9191.1
Review metrics
Recent advances in the management of acute ischemic stroke
[version 1; peer review: 2 approved]
Philip Chang, Shyam Prabhakaran
Peer Reviewers Seemant Chaturvedi; Adnan I. Qureshi
PUBLISHED 13 Apr 2017
https://doi.org/10.12688/f1000research.10729.1
Review metrics
Linking cortical microtubule attachment and exocytosis
[version 1; peer review: 2 approved]
Ivar Noordstra, Anna Akhmanova
Peer Reviewers Hiroyuki Ohkura and Ricardo Nunes Bastos; Torsten Wittmann
  • Funders
  • Netherlands Organization for Scientific Research
  • ERC Synergy
PUBLISHED 12 Apr 2017
https://doi.org/10.12688/f1000research.10510.1
Review metrics
Unwinding focal segmental glomerulosclerosis
[version 1; peer review: 3 approved]
Vasil Peev, Eunsil Hahm, Jochen Reiser
Peer Reviewers Vivekanand Jha; Johan van der Vlag; Kirk Campbell
PUBLISHED 12 Apr 2017
https://doi.org/10.12688/f1000research.10612.1
Review metrics
Advancing psychological therapies for chronic pain
[version 1; peer review: 2 approved]
Christopher Eccleston, Geert Crombez
Peer Reviewers Beverly Thorn; Susmita Kashikar-Zuck
PUBLISHED 11 Apr 2017
https://doi.org/10.12688/f1000research.10617.1
Review metrics
The rise of photoresponsive protein technologies applications in vivo: a spotlight on zebrafish developmental and cell biology
[version 1; peer review: 2 approved]
Renee Wei-Yan Chow, Julien Vermot
Peer Reviewers Filippo Del Bene; Periklis Pantazis and Manuel Alexander Mohr
  • Funders
  • European Research Council
  • ANR
  • Fondation pour la rechercher médicale
  • Investissements d’Avenir
  • EMBO Young Investigator Program
PUBLISHED 11 Apr 2017
https://doi.org/10.12688/f1000research.10768.1
Review metrics
Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy
[version 1; peer review: 3 approved]
Kjeld Schmiegelow, Klaus Müller, Signe Sloth Mogensen, Pernille Rudebeck Mogensen, Benjamin Ole Wolthers, Ulrik Kristoffer Stoltze, Ruta Tuckuviene, Thomas Frandsen
Peer Reviewers Chris Halsey; Anne Uyttebroeck; Jan Stary
  • Funders
  • Danish Cancer Society
  • Danish Childhood Cancer Foundation
PUBLISHED 07 Apr 2017
https://doi.org/10.12688/f1000research.10485.1
Review metrics
Type-1 metabotropic glutamate receptor signaling in cerebellar Purkinje cells in health and disease
[version 1; peer review: 3 approved]
Masanobu Kano, Takaki Watanabe
Peer Reviewers Alanna Watt and Visou Ady; Maria Concetta Miniaci; Ferdinando Nicoletti
  • Funders
  • AMED, Japan
  • Japan Society for the Promotion of Science
PUBLISHED 04 Apr 2017
https://doi.org/10.12688/f1000research.10233.1
Review metrics
New drugs in psychiatry: focus on new pharmacological targets
[version 1; peer review: 3 approved]
Filippo Caraci, Gian Marco Leggio, Salvatore Salomone, Filippo Drago
Peer Reviewers S. J. Enna; Philippe De Deurwaerdère; Andrzej Pilc and Michal Korostynski
PUBLISHED 30 Mar 2017
https://doi.org/10.12688/f1000research.10583.1
Review metrics
B-cell tolerance and autoimmunity
[version 1; peer review: 2 approved]
Takeshi Tsubata
Peer Reviewers Changchun Xiao; Robert Brink
PUBLISHED 29 Mar 2017
https://doi.org/10.12688/f1000research.10591.1
Review metrics
Recent advances in understanding Epstein-Barr virus
[version 1; peer review: 4 approved]
Brent A. Stanfield, Micah A. Luftig
Peer Reviewers Christian Münz; Alan K Chiang; Richard M. Longnecker; Bo Zhao
  • Funders
  • National Cancer Institute
  • National Institute of Dental and Craniofacial Research
PUBLISHED 29 Mar 2017
https://doi.org/10.12688/f1000research.10475.1
Review metrics
Bringing a genomic perspective to the safety of drug treatment in oncology
[version 1; peer review: 3 approved]
Federico Innocenti
Peer Reviewers Cristina Rodríguez-Antona; Giuliano Ciarimboli; Emile Voest
PUBLISHED 29 Mar 2017
https://doi.org/10.12688/f1000research.10476.1
Review metrics
What causes amyotrophic lateral sclerosis?
[version 1; peer review: 3 approved]
Sarah Martin, Ahmad Al Khleifat, Ammar Al-Chalabi
Peer Reviewers Robert P. Bowser; Richard W Orrell; Mamede de Carvalho
PUBLISHED 28 Mar 2017
https://doi.org/10.12688/f1000research.10572.1
Review metrics
RNA and Proteins: Mutual Respect
[version 1; peer review: 3 approved]
Kathleen B. Hall
Peer Reviewers Xiang-Dong Fu; Markus Wahl; Shinichi Nakagawa
PUBLISHED 27 Mar 2017
https://doi.org/10.12688/f1000research.10707.1
Review metrics
X chromosome inactivation: new players in the initiation of gene silencing
[version 1; peer review: 2 approved]
Ines Pinheiro, Edith Heard
Peer Reviewers Carolyn Brown; Christine Disteche
  • Funders
  • European Molecular Biology Organization
  • ANR project NonCodiX
  • IDEX Idex PSL 734
  • ABS4NGS
  • La Ligue, Paris Alliance of Cancer Research Institutes
  • Fondation pour la Recherche Médicale
  • Labex DEEP
PUBLISHED 27 Mar 2017
https://doi.org/10.12688/f1000research.10696.1
Review metrics
Wars between microbes on roots and fruits
[version 1; peer review: 3 approved]
Ben Lugtenberg, Daniel E. Rozen, Faina Kamilova
Peer Reviewers Choong-Min Ryu; Rainer Borriss; Corné Pieterse
PUBLISHED 27 Mar 2017
https://doi.org/10.12688/f1000research.10594.1
Review metrics
Studying human immunodeficiencies in humans: advances in fundamental concepts and therapeutic interventions
[version 1; peer review: 3 approved]
Helen Su
Peer Reviewers Ramsay Fuleihan; Jordan Orange; Andrew Gennery
  • Funder
  • National Institute of Allergy and Infectious Diseases
PUBLISHED 24 Mar 2017
921-940 of 2,125 FACULTY REVIEWS
Previous Next
PUBLISH YOUR RESEARCH
Articles
We publish a wide range of article types in science, engineering, medicine, social sciences and humanities, with no editorial biases.
SUBMIT AN ARTICLE
See guidelines and policies.
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.
Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.